Padmini Jayaraman

About

At the core, Padmini is a Cellular and Molecular Immunologist with 15 years of comprehensive training in both basic and clinical immunology, specializing in immunotherapy and targeted therapies for cancer, inflammation, and autoimmunity. Over the past seven years, she has developed strong business acumen and taken on significant responsibilities, including leading corporate strategy, pipeline development, commercialization of clinical assets, and overseeing critical partnerships and M&A activity across the life sciences sector, including oncology, infectious diseases, inflammation, cardiometabolic diseases, and autoimmunity.

She is passionate about advancing bench-to-bedside therapeutics and dedicated to fostering meaningful partnerships and collaborations. She thrives on networking and exchanging innovative ideas with like-minded professionals, remaining highly motivated to provide solutions and strategies that advance translational therapeutics. By blending deep scientific expertise with strong business acumen, she is well-positioned to drive innovation, leveraging a vast network across the Pharma/Biotech sector in the US, Europe, and Asia-Pacific to forge impactful collaborations across the life sciences ecosystem.